These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 28706518
1. Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice. Wang JL, Elsheikha HM, Zhu WN, Chen K, Li TT, Yue DM, Zhang XX, Huang SY, Zhu XQ. Front Immunol; 2017; 8():730. PubMed ID: 28706518 [Abstract] [Full Text] [Related]
2. Effect of deletion of gra17 and gra23 genes on the growth, virulence, and immunogenicity of type II Toxoplasma gondii. Li TT, Wang JL, Liang QL, Sun LX, Zhang HS, Zhang ZW, Zhu XQ, Elsheikha HM. Parasitol Res; 2020 Sep; 119(9):2907-2916. PubMed ID: 32686022 [Abstract] [Full Text] [Related]
3. Live Attenuated Pru:Δcdpk2 Strain of Toxoplasma gondii Protects Against Acute, Chronic, and Congenital Toxoplasmosis. Wang JL, Li TT, Elsheikha HM, Chen K, Cong W, Yang WB, Bai MJ, Huang SY, Zhu XQ. J Infect Dis; 2018 Jul 24; 218(5):768-777. PubMed ID: 29669003 [Abstract] [Full Text] [Related]
7. Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice. Ismael AB, Dimier-Poisson I, Lebrun M, Dubremetz JF, Bout D, Mevelec MN. J Infect Dis; 2006 Oct 15; 194(8):1176-83. PubMed ID: 16991094 [Abstract] [Full Text] [Related]
9. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ. Vaccine; 2013 Dec 16; 31(52):6225-31. PubMed ID: 24183979 [Abstract] [Full Text] [Related]
10. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL. Parasite Immunol; 2005 Dec 16; 27(1-2):29-35. PubMed ID: 15813720 [Abstract] [Full Text] [Related]
12. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice. Caetano BC, Bruña-Romero O, Fux B, Mendes EA, Penido ML, Gazzinelli RT. Hum Gene Ther; 2006 Apr 16; 17(4):415-26. PubMed ID: 16610929 [Abstract] [Full Text] [Related]
13. Toxoplasma gondiiADSL Knockout Provides Excellent Immune Protection against a Variety of Strains. Wang L, Tang D, Yang C, Yang J, Fang R. Vaccines (Basel); 2020 Jan 06; 8(1):. PubMed ID: 31935935 [Abstract] [Full Text] [Related]
16. Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis. Zhang NZ, Gao Q, Wang M, Elsheikha HM, Wang B, Wang JL, Zhang FK, Hu LY, Zhu XQ. Front Immunol; 2018 Jan 06; 9():1505. PubMed ID: 30008721 [Abstract] [Full Text] [Related]
17. Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models. Yang X, Huang S, Chen J, Song N, Wang L, Zhang Z, Deng G, Zheng H, Zhu XQ, Lu F. Vaccine; 2010 Jan 08; 28(3):737-43. PubMed ID: 19887128 [Abstract] [Full Text] [Related]
19. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice. Zheng B, Lu S, Tong Q, Kong Q, Lou D. Vaccine; 2013 Sep 23; 31(41):4578-84. PubMed ID: 23928460 [Abstract] [Full Text] [Related]